These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 17952649)

  • 1. Cannabinoids and multiple sclerosis.
    Pertwee RG
    Mol Neurobiol; 2007 Aug; 36(1):45-59. PubMed ID: 17952649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why do cannabinoids not show consistent effects as analgetic drugs in multiple sclerosis?
    Lienau FS; Füllgraf H; Moser A; Feuerstein TJ
    Eur J Neurol; 2007 Oct; 14(10):1162-9. PubMed ID: 17880571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of cannabinoids in multiple sclerosis.
    Teare L; Zajicek J
    Expert Opin Investig Drugs; 2005 Jul; 14(7):859-69. PubMed ID: 16022575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic potential of novel cannabinoid receptors.
    Kreitzer FR; Stella N
    Pharmacol Ther; 2009 May; 122(2):83-96. PubMed ID: 19248809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cannabinoids in multiple sclerosis.
    Zajicek JP; Apostu VI
    CNS Drugs; 2011 Mar; 25(3):187-201. PubMed ID: 21323391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids, endocannabinoids, and cancer.
    Hermanson DJ; Marnett LJ
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):599-612. PubMed ID: 22038019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.
    Rahn EJ; Hohmann AG
    Neurotherapeutics; 2009 Oct; 6(4):713-37. PubMed ID: 19789075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocannabinoid system and multiple sclerosis.
    Baker D; Pryce G
    Curr Pharm Des; 2008; 14(23):2326-36. PubMed ID: 18781983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic opportunities through modulation of the endocannabinoid system.
    Makriyannis A; Mechoulam R; Piomelli D
    Neuropharmacology; 2005 Jun; 48(8):1068-71. PubMed ID: 15885714
    [No Abstract]   [Full Text] [Related]  

  • 10. [News about therapeutic use of Cannabis and endocannabinoid system].
    Duran M; Laporte JR; Capellà D
    Med Clin (Barc); 2004 Mar; 122(10):390-8. PubMed ID: 15033046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Fu W; Taylor BK
    Neurosci Lett; 2015 May; 595():1-6. PubMed ID: 25849525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptors and pain.
    Pertwee RG
    Prog Neurobiol; 2001 Apr; 63(5):569-611. PubMed ID: 11164622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptors as therapeutic targets.
    Mackie K
    Annu Rev Pharmacol Toxicol; 2006; 46():101-22. PubMed ID: 16402900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards cannabis and cannabinoid treatment of multiple sclerosis.
    Croxford JL; Miller SD
    Drugs Today (Barc); 2004 Aug; 40(8):663-76. PubMed ID: 15510238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid signaling in health and disease.
    Lu Y; Anderson HD
    Can J Physiol Pharmacol; 2017 Apr; 95(4):311-327. PubMed ID: 28263083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the endocannabinoid system: future therapeutic strategies.
    Aizpurua-Olaizola O; Elezgarai I; Rico-Barrio I; Zarandona I; Etxebarria N; Usobiaga A
    Drug Discov Today; 2017 Jan; 22(1):105-110. PubMed ID: 27554802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endogenous cannabinoid system and its role in nociceptive behavior.
    Cravatt BF; Lichtman AH
    J Neurobiol; 2004 Oct; 61(1):149-60. PubMed ID: 15362158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists.
    Butler H; Korbonits M
    Eur J Endocrinol; 2009 Nov; 161(5):655-62. PubMed ID: 19729432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.